Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−8.94 USD
−3.70 M USD
253.57 K USD
1.86 M
About 60 Degrees Pharmaceuticals, Inc.
Sector
Industry
CEO
Geoffrey S. Dow
Website
Headquarters
Washington
Founded
2010
FIGI
BBG00NXBJGQ4
60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SXTP is 1.26 USD — it has decreased by −10.64% in the past 24 hours. Watch 60 Degrees Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange 60 Degrees Pharmaceuticals, Inc. stocks are traded under the ticker SXTP.
SXTP stock has fallen by −22.70% compared to the previous week, the month change is a 34.04% rise, over the last year 60 Degrees Pharmaceuticals, Inc. has showed a −92.34% decrease.
We've gathered analysts' opinions on 60 Degrees Pharmaceuticals, Inc. future price: according to them, SXTP price has a max estimate of 3.40 USD and a min estimate of 3.40 USD. Watch SXTP chart and read a more detailed 60 Degrees Pharmaceuticals, Inc. stock forecast: see what analysts think of 60 Degrees Pharmaceuticals, Inc. and suggest that you do with its stocks.
SXTP reached its all-time high on Jul 13, 2023 with the price of 103.80 USD, and its all-time low was 0.70 USD and was reached on Oct 30, 2024. View more price dynamics on SXTP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SXTP stock is 16.67% volatile and has beta coefficient of 2.33. Track 60 Degrees Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is 60 Degrees Pharmaceuticals, Inc. there?
Today 60 Degrees Pharmaceuticals, Inc. has the market capitalization of 2.89 M, it has decreased by −33.03% over the last week.
Yes, you can track 60 Degrees Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
60 Degrees Pharmaceuticals, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
SXTP earnings for the last quarter are −0.93 USD per share, whereas the estimation was −0.70 USD resulting in a −31.91% surprise. The estimated earnings for the next quarter are −0.80 USD per share. See more details about 60 Degrees Pharmaceuticals, Inc. earnings.
60 Degrees Pharmaceuticals, Inc. revenue for the last quarter amounts to 135.00 K USD, despite the estimated figure of 250.00 K USD. In the next quarter, revenue is expected to reach 250.00 K USD.
SXTP net income for the last quarter is −2.16 M USD, while the quarter before that showed −4.17 M USD of net income which accounts for 48.31% change. Track more 60 Degrees Pharmaceuticals, Inc. financial stats to get the full picture.
No, SXTP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 3.00 employees. See our rating of the largest employees — is 60 Degrees Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 60 Degrees Pharmaceuticals, Inc. EBITDA is −9.46 M USD, and current EBITDA margin is −1.99 K%. See more stats in 60 Degrees Pharmaceuticals, Inc. financial statements.
Like other stocks, SXTP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 60 Degrees Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 60 Degrees Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 60 Degrees Pharmaceuticals, Inc. stock shows the buy signal. See more of 60 Degrees Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.